Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
Public ClinicalTrials.gov record NCT01135992. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Trial Assessing the Implications of Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™: SIMPLIFY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA). The aim of this clinical trial is to assess the implications of switching from insulin glargine (IGlar) to insulin degludec (IDeg) in subjects with type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT01135992
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2010
- Primary completion
- Oct 31, 2010
- Completion
- Oct 31, 2010
- Last update posted
- Jan 21, 2016
2010
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Clinical Trial Call Center | Goodyear | Arizona | 85395 | — |
| Novo Nordisk Clinical Trial Call Center | Phoenix | Arizona | 85018 | — |
| Novo Nordisk Clinical Trial Call Center | Anaheim | California | 92801 | — |
| Novo Nordisk Clinical Trial Call Center | Chino | California | 91710 | — |
| Novo Nordisk Clinical Trial Call Center | Concord | California | 94520 | — |
| Novo Nordisk Clinical Trial Call Center | Fresno | California | 93720 | — |
| Novo Nordisk Clinical Trial Call Center | Greenbrae | California | 94904 | — |
| Novo Nordisk Clinical Trial Call Center | Palm Springs | California | 92262-6972 | — |
| Novo Nordisk Clinical Trial Call Center | Kissimmee | Florida | 34741 | — |
| Novo Nordisk Clinical Trial Call Center | Chicago | Illinois | 60616 | — |
| Novo Nordisk Clinical Trial Call Center | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Clinical Trial Call Center | Metairie | Louisiana | 70006-2930 | — |
| Novo Nordisk Clinical Trial Call Center | Omaha | Nebraska | 68114 | — |
| Novo Nordisk Clinical Trial Call Center | Henderson | Nevada | 89052-2649 | — |
| Novo Nordisk Clinical Trial Call Center | Dover | New Hampshire | 03820 | — |
| Novo Nordisk Clinical Trial Call Center | Nashua | New Hampshire | 03063 | — |
| Novo Nordisk Clinical Trial Call Center | Lawrenceville | New Jersey | 08648 | — |
| Novo Nordisk Clinical Trial Call Center | Toms River | New Jersey | 08755-8050 | — |
| Novo Nordisk Clinical Trial Call Center | Albany | New York | 12206 | — |
| Novo Nordisk Clinical Trial Call Center | Charlotte | North Carolina | 28209 | — |
| Novo Nordisk Clinical Trial Call Center | Melrose Park | Pennsylvania | 19027 | — |
| Novo Nordisk Clinical Trial Call Center | Pittsburgh | Pennsylvania | 15224-2215 | — |
| Novo Nordisk Clinical Trial Call Center | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Clinical Trial Call Center | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Clinical Trial Call Center | Austin | Texas | 78731 | — |
| Novo Nordisk Clinical Trial Call Center | Fort Worth | Texas | 76113 | — |
| Novo Nordisk Clinical Trial Call Center | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01135992, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 21, 2016 · Synced Sep 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01135992 live on ClinicalTrials.gov.